BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36716402)

  • 21. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G
    Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in antibiotic resistance in bacterial keratitis isolates from South India.
    Lalitha P; Manoharan G; Karpagam R; Prajna NV; Srinivasan M; Mascarenhas J; Das M; Porco TC; Lietman TM; Cevallos V; Keenan JD
    Br J Ophthalmol; 2017 Feb; 101(2):108-113. PubMed ID: 27130916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution and Antibiotic Resistance Analysis of Ocular Bacterial Pathogens at a Tertiary Hospital From 2012 to 2021].
    Zhou D; Wang Y; Deng J; Xiao Y; Xie Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):204-209. PubMed ID: 38322538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and microbiological in bacterial keratitis in a tertiary referral hospital.
    Ruiz Caro JM; Cabrejas L; de Hoz MR; Mingo D; Duran SP
    Arch Soc Esp Oftalmol; 2017 Sep; 92(9):419-425. PubMed ID: 28236499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the Microbiological Spectrum of Nonviral Keratitis at a Single Tertiary Care Ophthalmic Hospital in India: A Review of 30 years.
    Joseph J; Karoliya R; Sheba E; Sharma S; Bagga B; Garg P
    Cornea; 2023 Jul; 42(7):837-846. PubMed ID: 35942533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
    Sueke H; Kaye S; Neal T; Murphy C; Hall A; Whittaker D; Tuft S; Parry C
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
    Afshari NA; Ma JJ; Duncan SM; Pineda R; Starr CE; Decroos FC; Johnson CS; Adelman RA
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):217-23. PubMed ID: 18331204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of pathogen distribution and antimicrobial resistance at infected sites in plastic surgery.
    Jiang F; Su X; Dai Y; Shen H; Hu J; Wu L; Wu Y; Zhan S
    J Cosmet Dermatol; 2023 May; 22(5):1575-1584. PubMed ID: 36606385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.
    Gentile RC; Shukla S; Shah M; Ritterband DC; Engelbert M; Davis A; Hu DN
    Ophthalmology; 2014 Aug; 121(8):1634-42. PubMed ID: 24702755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases.
    Liu C; Ji J; Li S; Wang Z; Tang L; Cao W; Sun X
    Curr Eye Res; 2017 Mar; 42(3):443-447. PubMed ID: 27347700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of bacterial cultures in infectious keratitis, 1997 to 2004.
    Yeh DL; Stinnett SS; Afshari NA
    Am J Ophthalmol; 2006 Dec; 142(6):1066-8. PubMed ID: 17157596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.
    Orlans HO; Hornby SJ; Bowler IC
    Eye (Lond); 2011 Apr; 25(4):489-93. PubMed ID: 21252952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania.
    Ni N; Nam EM; Hammersmith KM; Nagra PK; Azari AA; Leiby BE; Dai Y; Cabrera FA; Ma JF; Lambert CE; Honig SE; Rapuano CJ
    Cornea; 2015 Mar; 34(3):296-302. PubMed ID: 25603231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microorganisms and Antibiotic Resistance of Bacterial Keratitis at a Rural County Hospital in Seville.
    Lorente Pascua J; García Bernal A; Garcia Sanchez E; Almeida González CV
    Eye Contact Lens; 2022 Jun; 48(6):267-271. PubMed ID: 35333821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Kowalski RP; Kowalski TA; Shanks RM; Romanowski EG; Karenchak LM; Mah FS
    Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study.
    Ting DSJ; Ho CS; Cairns J; Elsahn A; Al-Aqaba M; Boswell T; Said DG; Dua HS
    Br J Ophthalmol; 2021 Mar; 105(3):328-333. PubMed ID: 32580955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial keratitis in Southern Malawi: a microbiological pilot study.
    Somerville TF; Mdala S; Zungu T; Gandiwa M; Herbert R; Everett D; Corless CE; Beare NAV; Neal T; Horsburgh MJ; Darby A; Kaye SB; Kayange PC
    BMJ Open Ophthalmol; 2024 Apr; 9(1):. PubMed ID: 38653537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea.
    Mun Y; Kim MK; Oh JY
    PLoS One; 2019; 14(3):e0213103. PubMed ID: 30822325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends of Bacterial Keratitis Culture Isolates in Jerusalem; a 13- Years Analysis.
    Politis M; Wajnsztajn D; Rosin B; Block C; Solomon A
    PLoS One; 2016; 11(11):e0165223. PubMed ID: 27893743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.